“Operating on FBI approved chemistry, RapidHIT is a solution that can generate DNA profiles based on submitted reference samples. It has applications in lab settings, and on all ends of crime scene investigations.”
Today, Morpho (Safran) announced its partnership with rapid DNA technology and solutions provider IntegenX. The team-up will see Morpho marketing its partner’s RapidHIT System to government and law enforcement agencies in multiple countries.
Operating on FBI approved chemistry, RapidHIT is a solution that can generate DNA profiles based on submitted reference samples. It has applications in lab settings, and on all ends of crime scene investigations.
This fits well with Morpho’s always growing portfolio of biometric technologies, making the partners an excellent fit. The Safran company is already providing criminal identification technologies that leverage biometrics to the needing agencies on a global level. This international presence and Morpho’s familiarity with similar tech will aid in the marketing push for IntegenX’s DNA solution.
IntegenX president and CEO Robert Schueren spoke to the partnership saying, “IntegenX is committed to bringing Rapid DNA testing to the forefront of our communities. We are excited by the capabilities brought forward through our partnership with Morpho.”
“Our customers around the world look to us for the most innovative and efficient criminal investigation solutions,” adds Philippe Petitcolin, chairman and CEO of Morpho. “We are proud to collaborate with IntegenX to introduce rapid DNA identification to speed up crime solving in the field.”
The partnership is a demonstration of Morpho’s wide reach across the biometric industry verticals. Yesterday the company announced that its physical access control unit, MorphoAccess SIGMA, was awarded the Best of Biometrics award by the Security Industry Association. As we prepare to bring Physical Access Control Month to a close tomorrow, it is nice to see this kind of reminder that biometrics vendors don’t need to be pigeon holed into a single modality or area of application.
April 29, 2014 – by Peter B. Counter